The European Investment Bank (EIB) will lend up to €110 million to Dräger, a German company specialised in medical and safety technology.

Founded in Lübeck in 1889 (yes you read that right), Dräger will use the fresh financing to fund R&D projects in medical technology targeting life-saving systems such as anaesthesia devices and ventilators.

Jyrki Katainen, European Commission VP for Jobs, Growth, Investment and Competitiveness,, said: “The products and systems that Dräger is developing are making our lives safer and healthier. From intensive care monitoring systems to premature infant respirators, this European company is creating groundbreaking innovations. With the financing of €110 million from the EU’s bank supported by the Investment Plan for Europe, Dräger can continue to push boundaries in medical technology.”

ICYMI: Throughout May, is focused on surfacing interesting stories, startups and people from the health/medtech industry, powered by Bayer G4A. With this program, the health industry giant aims to establish long-term partnerships with interesting digital health startups.

Comments are closed.